title: Serum free estradiol and estrogen receptor-α mediated activity are related to decreased incident hip fractures in older women.
abstract: There is paucity of data from Asian women on the association between serum estrogens and osteoporotic hip fracture risk. We conducted a case-control study nested within a population-based prospective cohort, The Singapore Chinese Health Study, to evaluate serum estrogens levels, ERα-mediated estrogenic activity and hip fracture risk in postmenopausal Asian women. Among 35,298 women who were recruited between 1993 and 1998, 15,410 women donated blood for research between 1999 and 2004. From this subcohort, we identified 140 cases who subsequently suffered hip fracture after blood donation, and 278 age-matched controls. Serum levels of total estrone, estradiol and sex hormone binding globulin levels were measured in a blinded fashion among cases and controls. ERα-mediated estrogenic activity of serum samples was quantified using a sensitive ERα-driven cell bioassay. Women with hip fracture had lower serum estrogens than control women. Compared to the lowest quintile, women in the highest quintile of free estradiol exhibited a statistically significant 57% reduction in risk of hip fracture (95% confidence interval (CI), 6-80%), with a dose-dependent relationship (p for trend=0.021). High levels of ERα-mediated estrogenic activity were also associated with decreased risk of hip fracture (p for trend=0.048). Overall, women with relatively high levels of both free estradiol and ERα-mediated estrogenic activity had a 55% reduction in hip fracture risk (95% CI, 17-76%) compared to women with low levels of both. High levels of free estradiol and ERα-mediated estrogen activity in sera were associated with reduced hip fracture risk in Chinese postmenopausal women.
authors.affiliation: Department of Obstetrics & Gynecology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
authors.forename: Vanessa W
authors.initials: VW
authors.lastname: Lim
authors.forename: Jun
authors.initials: J
authors.lastname: Li
authors.forename: Yinhan
authors.initials: Y
authors.lastname: Gong
authors.forename: Jian-Min
authors.initials: JM
authors.lastname: Yuan
authors.forename: Tsung Sheng
authors.initials: TS
authors.lastname: Wu
authors.forename: Geoffrey L
authors.initials: GL
authors.lastname: Hammond
authors.forename: Aizhen
authors.initials: A
authors.lastname: Jin
authors.forename: Woon-Puay
authors.initials: WP
authors.lastname: Koh
authors.forename: E L
authors.initials: EL
authors.lastname: Yong
mesh_terms: D000368:Aged; D016022:Case-Control Studies; D015331:Cohort Studies; D004958:Estradiol / Q000097:blood*; D047628:Estrogen Receptor alpha / Q000378:metabolism*; D004970:Estrone / Q000097:blood; D005260:Female; D006620:Hip Fractures / Q000097:blood* / Q000453:epidemiology / Q000378:metabolism*; D006801:Humans; D008875:Middle Aged; D011446:Prospective Studies; D012307:Risk Factors; D012738:Sex Hormone-Binding Globulin / Q000378:metabolism; D012846:Singapore / Q000453:epidemiology
chemical_list: C506487:ESR1 protein, human; D047628:Estrogen Receptor alpha; D012738:Sex Hormone-Binding Globulin; D004970:Estrone; D004958:Estradiol